Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy
- PMID: 17109182
- DOI: 10.1007/s00281-006-0045-0
Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy
Abstract
The recreational use of legal and illegal drugs has significant effects on immune responses and can potentially modulate susceptibility to infection by a number of pathogens. A number of agents including cannabinoids (marijuana), cocaine opiates, amphetamines, nicotine and alcohol were demonstrated to have potentially adverse effects on the susceptibility to infections, mediated most likely, by adverse effects on immunity. As such, these drugs of abuse could have significant and potentially adverse effects on the vaccination efficacy of a number of vaccines currently on the market and on potential experimental vaccines currently in the pipeline. This review will present an overview on how drugs of abuse potentially impacts immune responses and vaccination efficacy. The emphasis of this review will be the effects of opiate abuse, as exemplified by injecting/intravenous drug users (IDU), on HIV/AIDS and its potential impact on vaccine efficacy trials against this devastating infection/syndrome.
Similar articles
-
Addictive drugs and their relationship with infectious diseases.FEMS Immunol Med Microbiol. 2006 Aug;47(3):330-42. doi: 10.1111/j.1574-695X.2006.00097.x. FEMS Immunol Med Microbiol. 2006. PMID: 16872369 Review.
-
Will preventive HIV vaccine efficacy trials be possible with female injection drug users?J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15;10(5):577-85. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 8548338
-
[Prevalence of HIV infection among drug users in Zuid-Limburg].Ned Tijdschr Geneeskd. 1995 Sep 23;139(38):1936-40. Ned Tijdschr Geneeskd. 1995. PMID: 7477534 Dutch.
-
[HIV infection in intravenous drug addicts].Rev Med Interne. 1993;14(10):998. doi: 10.1016/s0248-8663(05)80116-x. Rev Med Interne. 1993. PMID: 8009091 French.
-
Bacterial infections in drug users.N Engl J Med. 2005 Nov 3;353(18):1945-54. doi: 10.1056/NEJMra042823. N Engl J Med. 2005. PMID: 16267325 Review. No abstract available.
Cited by
-
Substance use patterns of HVTN phase I clinical trial participants: Enrollment, risk reduction counseling and retention.Vaccine. 2018 Feb 21;36(9):1235-1242. doi: 10.1016/j.vaccine.2017.11.032. Vaccine. 2018. PMID: 29395528 Free PMC article.
-
Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses.J Hepatol. 2010 Nov;53(5):805-16. doi: 10.1016/j.jhep.2010.05.013. Epub 2010 Jul 17. J Hepatol. 2010. PMID: 20688412 Free PMC article.
-
Immunology as it pertains to drugs of abuse, AIDS and the neuroimmune axis: mediators and traffic.J Neuroimmune Pharmacol. 2011 Mar;6(1):20-7. doi: 10.1007/s11481-010-9247-2. Epub 2010 Oct 19. J Neuroimmune Pharmacol. 2011. PMID: 20957520 Free PMC article. Review.
-
Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users.AIDS. 2010 Sep 10;24(14):2151-60. doi: 10.1097/QAD.0b013e32833dfc20. AIDS. 2010. PMID: 20647906 Free PMC article.
-
Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor.J Pharmacol Exp Ther. 2010 Apr;333(1):319-27. doi: 10.1124/jpet.109.163055. Epub 2010 Jan 20. J Pharmacol Exp Ther. 2010. PMID: 20089805 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials